VIMTALABS Q4 FY26 Guidance vs Delivery (VIMTALABS Management Mirror)

Revenue & Growth Strategy

Management expects to maintain its historical 5 to 7-year CAGR trajectory to achieve a targeted 500 million run-rate in the near future, primarily driven by pharmaceutical and food testing services which constitute 90% of revenues. The broader long-term top-line target (previously stated as INR 500 crores for FY26) was consistently maintained across the Sep'25 and Dec'25 quarters, with the Dec'25 Qtr noting an expected sequential revenue improvement for the Mar'26 Qtr despite potentially missing the INR 125 crore quarterly run rate. [Status: Reaffirmed]